Mirae Asset Global Etfs Holdings Ltd. Biomarin Pharmaceutical Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 44,047 shares of BMRN stock, worth $2.83 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,047
Previous 52,348
15.86%
Holding current value
$2.83 Million
Previous $4.31 Million
28.15%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
636Shares Held
178MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.46 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.24 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.21 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$893 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$674 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...